Eqis Capital Management, Inc. recently filed their 13F report for the second quarter of 2022, which ended on 2022-06-30.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
1000 4TH ST., STE 650 SAN RAFAEL, CA 94901
As of the latest 13F report, the guru’s equity portfolio contained 730 stocks valued at a total of $937.00Mil. The top holdings were TLT(3.28%), BIL(2.20%), and FHLC(1.44%).
According to GuruFocus data, these were Eqis Capital Management, Inc.’s top five trades of the quarter.
Fidelity MSCI Health Care Index ETF
During the quarter, Eqis Capital Management, Inc. bought 204,041 shares of ARCA:FHLC for a total holding of 222,672. The trade had a 1.32% impact on the equity portfolio. During the quarter, the stock traded for an average price of $62.13.
On 08/08/2022, Fidelity MSCI Health Care Index ETF traded for a price of $63.38 per share and a market cap of $3.00Bil. The stock has returned -4.14% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
In terms of valuation, Fidelity MSCI Health Care Index ETF has a price-earnings ratio of 21.78 and a price-book ratio of 4.38.
Fidelity MSCI Information Technology Index ETF
Eqis Capital Management, Inc. reduced their investment in ARCA:FTEC by 83,916 shares. The trade had a 0.93% impact on the equity portfolio. During the quarter, the stock traded for an average price of $106.6.
On 08/08/2022, Fidelity MSCI Information Technology Index ETF traded for a price of $111.26 per share and a market cap of $5.80Bil. The stock has returned -8.82% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
In terms of valuation, Fidelity MSCI Information Technology Index ETF has a price-earnings ratio of 22.65 and a price-book ratio of 6.92.
Vanguard Energy ETF
Eqis Capital Management, Inc. reduced their investment in ARCA:VDE by 73,552 shares. The trade had a 0.71% impact on the equity portfolio. During the quarter, the stock traded for an average price of $110.8.
On 08/08/2022, Vanguard Energy ETF traded for a price of $103.19 per share and a market cap of $7.17Bil. The stock has returned 55.36% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
In terms of valuation, Vanguard Energy ETF has a price-earnings ratio of 13.66 and a price-book ratio of 2.14.
SPDR Bloomberg 1-3 Month T-Bill ETF
Eqis Capital Management, Inc. reduced their investment in ARCA:BIL by 84,367 shares. The trade had a 0.69% impact on the equity portfolio. During the quarter, the stock traded for an average price of $91.27.
On 08/08/2022, SPDR Bloomberg 1-3 Month T-Bill ETF traded for a price of $91.43 per share and a market cap of $17.53Bil. The stock has returned 0.18% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
Fidelity MSCI Materials Index ETF
During the quarter, Eqis Capital Management, Inc. bought 142,773 shares of ARCA:FMAT for a total holding of 171,639. The trade had a 0.62% impact on the equity portfolio. During the quarter, the stock traded for an average price of $46.89.
On 08/08/2022, Fidelity MSCI Materials Index ETF traded for a price of $43.61 per share and a market cap of $442.64Mil. The stock has returned -5.81% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
In terms of valuation, Fidelity MSCI Materials Index ETF has a price-earnings ratio of 12.09 and a price-book ratio of 2.54.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
